These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18057881)

  • 1. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition.
    Lin C; Ke X; Ranade V; Somberg J
    Cardiology; 2008; 110(3):145-52. PubMed ID: 18057881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids.
    Zitron E; Scholz E; Owen RW; Lück S; Kiesecker C; Thomas D; Kathöfer S; Niroomand F; Kiehn J; Kreye VA; Katus HA; Schoels W; Karle CA
    Circulation; 2005 Feb; 111(7):835-8. PubMed ID: 15710766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation.
    Scholz EP; Zitron E; Kiesecker C; Lück S; Thomas D; Kathöfer S; Kreye VA; Katus HA; Kiehn J; Schoels W; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):516-25. PubMed ID: 16007460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
    Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide.
    Lin C; Ke X; Ranade V; Somberg J
    Cardiology; 2008; 110(3):209-16. PubMed ID: 18057887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
    Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
    Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
    DU CY; El Harchi A; Zhang YH; Orchard CH; Hancox JC
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1163-70. PubMed ID: 21489024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
    Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of extracellular acidosis on the effect of IKr blockers.
    Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):67-76. PubMed ID: 15821840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
    Lin C; Ke X; Cvetanovic I; Ranade V; Somberg J
    Cardiology; 2007; 108(1):18-27. PubMed ID: 16960444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels.
    Lin C; Cvetanovic I; Ke X; Ranade V; Somberg J
    Am J Ther; 2005; 12(4):328-36. PubMed ID: 16041196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The grapefruit polyphenol naringenin inhibits multiple cardiac ion channels.
    Sanson C; Boukaiba R; Houtmann S; Maizières MA; Fouconnier S; Partiseti M; Bohme GA
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):735-740. PubMed ID: 35412073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.
    Yang BF; Xu DH; Xu CQ; Li Z; Du ZM; Wang HZ; Dong DL
    Acta Pharmacol Sin; 2004 May; 25(5):554-60. PubMed ID: 15132818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive Inhibition of HERG Channels Expressed in Xenopus Oocytes by Antipsychotic Drugs and Citrus Juice Flavonoid Naringenin.
    Yang KS; Isaev D; Oz M
    Pharmacology; 2024 Sep; ():1-5. PubMed ID: 39326403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action.
    Kushida S; Ogura T; Komuro I; Nakaya H
    Eur J Pharmacol; 2002 Dec; 457(1):19-27. PubMed ID: 12460639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drug carvedilol inhibits HERG potassium channels.
    Karle CA; Kreye VA; Thomas D; Röckl K; Kathöfer S; Zhang W; Kiehn J
    Cardiovasc Res; 2001 Feb; 49(2):361-70. PubMed ID: 11164846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
    Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S
    J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic-pharmacodynamic model for the quantitative prediction of dofetilide clinical QT prolongation from human ether-a-go-go-related gene current inhibition data.
    Jonker DM; Kenna LA; Leishman D; Wallis R; Milligan PA; Jonsson EN
    Clin Pharmacol Ther; 2005 Jun; 77(6):572-82. PubMed ID: 15961988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.